Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia

• Main Author: Melaku Tadege
• Format: Article
• Language: English
• Published: BMC 2018-10-01
• Series: BMC Research Notes
• Subjects: HIV; ART; TB; Survival
• Online Access: http://link.springer.com/article/10.1186/s13104-018-3863-y

Abstract Objective The purpose of this study was to identify the major risk factors, which contributed to shortened survival time to death of HIV patients on antiretroviral therapy. Six-hundred HIV patients were included from two hospitals and six health centers record from January 2003 to December 2017. Kaplan–Meier and Cox proportional hazard model were implemented. Results From the Kaplan–Meier, log-rank test result indicated that there was a significant difference between tuberculosis comorbidity (P = .000), occupation (P = .027), and WHO clinical stage (P = .012) on the survival experience of patients at 5% statistical significance level. From the Cox regression result, the risk of death for patients who lived with tuberculosis was about 2.872-fold times higher than those patients who were negative. Most of the HIV/AIDS patients on antiretroviral therapy were died in a short period due to tuberculosis comorbidity, began with lower amount of CD4, being underweight, merchant, and being on WHO clinical stage IV.